Sam S. Chang
University of California, Los Angeles(US)NYU Langone Health(US)Miami Transplant Institute(US)National Institute for Radiological Protection(CN)New York University(US)Vanderbilt University Medical Center(US)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Urological Disorders and Treatments, Inflammatory Bowel Disease, Microscopic Colitis
Most-Cited Works
- → Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline(2016)1,353 cited
- → Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity(2016)1,087 cited
- → PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression(2017)954 cited
- → Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline(2017)926 cited
- → Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update(2007)837 cited
- Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.(1999)
- → Deubiquitination and Stabilization of PD-L1 by CSN5